8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2019 / Systematic review of systematic reviews
This systematic review of systematic reviews evaluated the effects of workplace dietary intervention components on diet-, health-, and economic-related outcomes based on searches updated through August 2017. Twenty-one systematic reviews (published in twenty-two papers) met inclusion criteria, with most rated as moderate quality. Evidence was strongest for interventions designed to increase fruit and vegetable intake, reduce fat intake, aid weight loss, and reduce cholesterol. Few included reviews reported on workplace-related and evaluation outcomes.
Schliemann D, Woodside JV Public Health Nutr, 2019. PMID 30706845
2019 / Umbrella review of observational studies
An umbrella review examined quantitative syntheses of observational studies linking produce intake with health outcomes. Probable evidence was observed for cardiovascular protection, while possible evidence indicated lower risks of colon malignancies, depressive disorders, and pancreatic ailments for fruits. For vegetable consumption, possible evidence supported lower risks of stroke, hip fractures, colorectal malignancies, depression, and pancreatic conditions, though geographical location and sex were potential confounding factors.
Shows an association, not proof of cause and effect.
Angelino D, Godos J, Ghelfi F, et al. Int J Food Sci Nutr, 2019. PMID 30764679
2019 / Pooled analysis of 6 prospective cohort studies
Individual participant data from 6 prospective US cohorts were pooled across a median follow-up of 17.5 years, identifying 5,400 incident CVD events and 6,132 all-cause deaths. Each additional 300 mg of dietary cholesterol per day was associated with higher risks of incident CVD (adjusted HR, 1.17 [95% CI, 1.09-1.26]) and all-cause mortality (adjusted HR, 1.18 [95% CI, 1.10-1.26]). Similarly, each additional half an egg per day was linked to higher risk of incident CVD (adjusted HR, 1.06 [95% CI, 1.03-1.10]) and all-cause mortality (adjusted HR, 1.08 [95% CI, 1.04-1.11]). However, the associations for egg consumption were no longer significant after adjusting for dietary cholesterol intake.
Shows an association, not proof of cause and effect.
Zhong VW, Van Horn L, Cornelis MC, et al. JAMA, 2019. PMID 30874756
2019 / Meta-analysis of randomized controlled trials
A meta-analysis of 36 randomized controlled trials including 1,803 participants evaluated the effect of red meat against alternative diets on cardiovascular risk markers. Across all comparisons combined, red meat showed no significant differences for blood pressure, apolipoproteins, or cholesterol, though it reduced triglycerides less (WMD 0.065 mmol/L; 95% CI, 0.000 to 0.129). Replacing red meat with high-quality plant proteins yielded greater reductions in total cholesterol (WMD 0.264 mmol/L) and LDL cholesterol (WMD 0.198 mmol/L).
Guasch-Ferré M, Satija A, Blondin SA, et al. Circulation, 2019. PMID 30958719
2019 / Review of systematic reviews and meta-analyses
Researchers conducted a systematic search of PubMed to review evidence from systematic reviews or meta-analyses on dietary components, cardiovascular disease, and all-cause mortality (including 16 reviews for mortality and 17 for CVD). Reductions in all-cause mortality were linked to whole grain bread (RR 0.85, 95% CI 0.82-0.89), breakfast cereal (RR 0.88), oats/oatmeal (RR 0.88), root vegetables (RR 0.76, 95% CI 0.66-0.88), green leafy vegetables/salad (RR 0.78), cooked vegetables (RR 0.89), cruciferous vegetables (RR 0.90), fish (RR 0.98), and nuts (RR 0.78). Increased all-cause mortality was linked to processed meat (RR 1.25, 95% CI 1.07-1.45) and tinned fruit (RR 1.14, 95% CI 1.07-1.21). Similar beneficial associations with cardiovascular disease were observed for carbohydrates, nuts, and fish, while red meat and processed meat were associated with harm.
Shows an association, not proof of cause and effect.
Kwok CS, Gulati M, Michos ED, et al. Eur J Prev Cardiol, 2019. PMID 30971126
2019 / Prospective cohort study and meta-analysis of prospective cohort studies
Researchers examined the link between low-carbohydrate diet (LCD) scores and mortality using NHANES (1999-2010) data and a pooled analysis of nine prospective cohort studies. In NHANES (24,825 participants), those in the lowest carbohydrate quartile had the highest risk of overall (32%), CVD (50%), cerebrovascular (51%), and cancer (36%) mortality compared to the highest carbohydrate intake quartile. In the pooled analysis of nine cohorts (462,934 participants), LCD was associated with higher overall (RR 1.22, 95% CI 1.06-1.39), CVD (RR 1.13, 95% CI 1.02-1.24), and cancer mortality (RR 1.08, 95% CI 1.01-1.14). The authors noted that causality cannot be proven and residual bias cannot be ruled out.
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Eur Heart J, 2019. PMID 31004146
2019 / Systematic review of controlled trials
A systematic review searched six databases for randomized and nonrandomized controlled trials investigating whether dietary supplements or pharmacological agents affect TMAO concentrations in adults. Thirteen eligible trials were identified, comprising 6 studies on dietary supplements (mostly randomized controlled trials) and 7 on pharmacological agents. Different interventional products were tested, and the studies lacked the consistency to reliably synthesize evidence for the modifiability of TMAO concentrations by dietary supplements or pharmacological agents.
Kalagi NA, Abbott KA, Alburikan KA, et al. Adv Nutr, 2019. PMID 31073588
2019 / Systematic review of controlled studies
A systematic review evaluated the health promotion effects of immersive nature-experiences across 133 controlled studies. Positive effects were reported for psychological wellbeing (≈55% positive of n=97), psychosocial function (≈61% positive of n=67), psychophysiological stress response (≈58% positive of n=50), cognitive performance (≈58% positive of n=36), and social skills and relationships (≈70% positive of n=34). Findings for physical health, such as cardiovascular disease risk, were less consistent (≈37% positive, ≈28% mixed, ≈35% non-significant of n=51). Across interventions and outcomes, the overall quality of the evidence was deemed low and occasionally moderate.
Mygind L, Kjeldsted E, Hartmeyer RD, et al. Front Psychol, 2019. PMID 31130890
2019 / Systematic review
A systematic review was conducted examining the last 10 years of literature on polyphenol intake and its association with disease markers and endpoints. Main dietary sources identified included tea, coffee, red wine, fruit, and vegetables. Intake of total flavonoids and specific subclasses, though not total polyphenols, was associated with a lower risk of diabetes, cardiovascular events, and all-cause mortality. The authors noted that large variability in methods for evaluating and quantifying intake, markers, and endpoints makes it difficult to establish an evidence-based reference intake.
Shows an association, not proof of cause and effect.
Del Bo' C, Bernardi S, Marino M, et al. Nutrients, 2019. PMID 31208133
2019 / Meta-analysis of randomized clinical trials
A meta-analysis of 21 randomized clinical trials evaluated the effect of long-term (≥1 year) vitamin D supplementation in 83,291 participants (41,669 receiving vitamin D, 41,622 receiving placebo). Vitamin D supplementation was not associated with reduced major adverse cardiovascular events (RR, 1.00; 95% CI, 0.95-1.06; P = .85) or all-cause mortality (RR, 0.97; 95% CI, 0.93-1.02; P = .23). No significant reductions were seen for myocardial infarction (RR, 1.00; 95% CI, 0.93-1.08), stroke (RR, 1.06; 95% CI, 0.98-1.15), or CVD mortality (RR, 0.98; 95% CI, 0.90-1.07). The abstract notes that only 4 trials prespecified CVD as a primary endpoint.
Barbarawi M, Kheiri B, Zayed Y, et al. JAMA Cardiol, 2019. PMID 31215980
2019 / Umbrella review of meta-analyses of observational studies
An umbrella review examined 96 meta-analyses covering 40 unique health outcomes to assess associations with tea consumption. An increment of two to three cups per day was associated with reduced risks of total mortality, cardiac death, coronary artery disease, stroke, and type 2 diabetes mellitus, alongside beneficial associations for several cancers, skeletal, cognitive, and maternal outcomes. Harmful associations were identified for esophageal and gastric cancer when tea was consumed at temperatures above 55-60 °C. The authors state that randomized controlled trials are needed to determine causality.
Shows an association, not proof of cause and effect.
Yi M, Wu X, Zhuang W, et al. Mol Nutr Food Res, 2019. PMID 31216091
2019 / Cumulative meta-analysis of randomized controlled trials
In a cumulative meta-analysis of 46 randomized controlled trials evaluated by the FDA, soy consumption consistently lowered blood lipids over 14 years. For LDL cholesterol, average decreases were -6.3 mg/dL (95% CI: -8.7 to -3.9 mg/dL; P=0.00001) in 1999 and subsequently spanned -4.2 to -6.7 mg/dL (P=0.0006 to P=0.0002). Total cholesterol reductions also preserved statistical significance across all evaluated time points.
Jenkins DJA, Blanco Mejia S, Chiavaroli L, et al. J Am Heart Assoc, 2019. PMID 31242779
2019 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 23 prospective cohorts involving 330,826 participants. Intake of soy products was inversely associated with cancer mortality (RR 0.88, 95% CI 0.79 to 0.99) and cardiovascular mortality (ES 0.85, 95% CI 0.72 to 0.99). Additionally, each 10-mg daily increment of soy isoflavones was linked to lower risk of death from all cancers and breast cancer, while soy protein was not tied to all-cause mortality.
Shows an association, not proof of cause and effect.
Nachvak SM, Moradi S, Anjom-Shoae J, et al. J Acad Nutr Diet, 2019. PMID 31278047
2019 / Meta-analysis of prospective cohorts
A meta-analysis of 19 prospective cohort studies examined total and specific nut consumption in relation to cardiovascular outcomes. Comparing highest with lowest intake categories, total nuts were inversely associated with cardiovascular incidence (RR 0.85; 95% CI 0.80-0.91) and mortality (RR 0.77; 95% CI 0.72-0.82), alongside coronary heart disease, stroke mortality, and atrial fibrillation. No significant associations appeared for stroke incidence or heart failure, and evidence certainty ranged from moderate to very low.
Shows an association, not proof of cause and effect.
Becerra-Tomás N, Paz-Graniel I, W C Kendall C, et al. Nutr Rev, 2019. PMID 31361320
2019 / Systematic review and meta-analysis of cohort studies
A meta-analysis evaluated 61 articles detailing 55 cohorts with over 4 million adults. Low-certainty evidence linked a reduction of 3 servings per week of unprocessed red meat to very small risk reductions in cardiovascular mortality, stroke, myocardial infarction, and type 2 diabetes. A 3-serving weekly reduction in processed meat was similarly linked to very small risk reductions for all-cause mortality, cardiovascular mortality, stroke, myocardial infarction, and type 2 diabetes.
Shows an association, not proof of cause and effect.
Zeraatkar D, Han MA, Guyatt GH, et al. Ann Intern Med, 2019. PMID 31569213
2019 / Systematic review and meta-analysis of prospective cohorts
Reviewers synthesized prospective cohort studies following participants for 2 to 34 years to evaluate dietary patterns with varying red and processed meat content. Low- to very-low-certainty evidence indicated that patterns lower in red and processed meat were linked to very small decreases in all-cause mortality, cardiovascular mortality, cancer mortality, and type 2 diabetes. Total sample sizes ranged from 4,000 to over 400,000 individuals across outcomes.
Shows an association, not proof of cause and effect.
Vernooij RWM, Zeraatkar D, Han MA, et al. Ann Intern Med, 2019. PMID 31569217
2019 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis of 10 observational studies evaluated baseline dog ownership and subsequent mortality among 3,837,005 participants with a mean follow-up of 10.1 years. Dog ownership was associated with a 24% risk reduction for all-cause mortality compared to nonownership (RR 0.76; 95% CI, 0.67-0.86), and among individuals with prior coronary events, it was associated with an RR of 0.35 (95% CI, 0.17-0.69). For cardiovascular mortality, dog ownership was associated with a 31% risk reduction (RR 0.69; 95% CI, 0.67-0.71). A noted possible limitation was that the analyses were not adjusted for confounders.
Shows an association, not proof of cause and effect.
Kramer CK, Mehmood S, Suen RS Circ Cardiovasc Qual Outcomes, 2019. PMID 31592726
2019 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 6 randomized clinical trials evaluated the effect of exercise training on circulating endothelial progenitor cells (EPCs) in 236 patients with cardiovascular disease. Overall, exercise training increased EPC levels (effect size [ES] = 0.57; 95% CI: 0.01-1.12), though heterogeneity was considerable (I2 = 75.6%; p < 0.001). In subgroup analyses, patients with heart failure experienced a significant increase in EPCs (ES = 0.52; 95% CI: 0.15-0.90; I2 = 0.0%), whereas no significant increase was observed in patients with arterial disease (ES = 0.67; 95% CI: -0.70-2.04; I2 = 91.2%).
Cavalcante SL, Lopes S, Bohn L, et al. Rev Port Cardiol (Engl Ed), 2019. PMID 32037059
2018 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 10 randomized controlled trials with 374 adult participants evaluated the effect of nut consumption on vascular endothelial function measured by flow-mediated dilation (FMD). Overall, nut consumption significantly improved FMD (WMD: 0.41%; 95% CI: 0.18%, 0.63%; P = 0.001), with moderate heterogeneity (I2 = 39.5%, P = 0.094). In subgroup analyses, walnuts significantly improved FMD (WMD: 0.39%; 95% CI: 0.16%, 0.63%; P = 0.001), while benefits were also observed in trials lasting <18 weeks, with doses <67 g/d, or in subjects with baseline FMD ≥8.6%. The authors noted that the beneficial effect was limited to walnuts and more studies on other nuts are needed.
Xiao Y, Huang W, Peng C, et al. Clin Nutr, 2018. PMID 28457654
2018 / Umbrella review of meta-analyses
An umbrella review analyzed 13 meta-analyses of observational studies and 16 meta-analyses of RCTs assessing adherence to the Mediterranean diet across 37 health outcomes in over 12,800,000 subjects. Robust evidence (P < 0.001, large sample size, and not considerable heterogeneity) supported an association between greater adherence and reduced risks of overall mortality, cardiovascular diseases, coronary heart disease, myocardial infarction, overall cancer incidence, neurodegenerative diseases, and diabetes. Evidence was only suggestive or weak for most site-specific cancers, inflammatory, and metabolic parameters. No evidence was reported for bladder, endometrial, and ovarian cancers, or LDL-cholesterol levels.
Shows an association, not proof of cause and effect.
Dinu M, Pagliai G, Casini A, et al. Eur J Clin Nutr, 2018. PMID 28488692
2018 / Meta-analysis of randomized controlled trials
A meta-analysis of 22 randomized controlled trials with 1,886 subjects investigated the efficacy and safety of sugarcane policosanol on dyslipidemia. Compared with placebo, sugarcane policosanol significantly reduced total cholesterol (95% CI: -0.87 to -0.30 mmol/L) and LDL-c (95% CI: -1.02 to -0.40 mmol/L), and increased HDL-c, but showed no significant effects on triglycerides or body weight. Adverse effects analysis indicated it was safer than control agents. Subgroup analysis revealed studies from Cuba showed greater effects than those conducted elsewhere, effects were not dose-proportional, and high heterogeneity was observed.
Gong J, Qin X, Yuan F, et al. Mol Nutr Food Res, 2018. PMID 28730734
2018 / Meta-analysis of randomized controlled trials
A meta-analysis of 19 randomized controlled trials with 797 subjects assessed Chlorella supplementation on cardiovascular risk markers. Chlorella significantly reduced total cholesterol by -9.09 mg/dL (95% CI -12.91 to -5.26), LDL cholesterol by -8.32 mg/dL (95% CI -12.22 to -4.42), systolic blood pressure by -4.51 mmHg (95% CI -6.53 to -2.48), diastolic blood pressure by -1.64 mmHg (95% CI -3.28 to -0.01), and fasting blood glucose by -4.23 mg/dL (95% CI -8.29 to -0.17). Triglycerides, HDL cholesterol, and BMI did not change significantly.
Fallah AA, Sarmast E, Habibian Dehkordi S, et al. Clin Nutr, 2018. PMID 29037431
2018 / Systematic review and dose-response meta-analysis
A meta-analysis of 19 cohort studies including 1,041,692 participants and 96,710 deaths evaluated whole grain intake and mortality risk. Comparing highest versus lowest intake categories showed pooled relative risks of 0.84 (95% CI 0.81-0.88) for all-cause, 0.83 (95% CI 0.79-0.86) for cardiovascular, and 0.94 (95% CI 0.87-1.01) for cancer mortality. Each 28 g/day intake was associated with relative risks of 0.91, 0.86, and 0.97 for total, cardiovascular, and cancer mortality, respectively.
Zhang B, Zhao Q, Guo W, et al. Eur J Clin Nutr, 2018. PMID 29091078
2018 / Meta-analysis of prospective cohorts
Researchers evaluated prospective cohort studies examining saturated fat intake and stroke subtypes across Japanese and non-Japanese populations. In Japanese cohorts, higher saturated fat intake was linked to lower risks of intracerebral hemorrhage (3 studies, HR 0.55, 95% CI 0.32-0.94) and ischemic stroke (4 studies, HR 0.82, 95% CI 0.71-0.93). Conversely, no significant inverse associations were observed in non-Japanese cohorts for either stroke subtype.
Shows an association, not proof of cause and effect.
Muto M, Ezaki O J Atheroscler Thromb, 2018. PMID 29269706